Zydus receives EIR for oncology injectable manufacturing facility in Ahmedabad SEZ1
The facility has been classified as Voluntary Action Indicated
The facility has been classified as Voluntary Action Indicated
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Agency initiates safety label change and notifies physicians of possible link
Clinical evidence has consistently highlighted lacosamide’s efficacy and safety.
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
Subscribe To Our Newsletter & Stay Updated